WAVE Life Sciences Ltd.
WVE
$13.02
-$0.33-2.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -110.68% | 14.43% | -76.74% | -82.16% | -68.67% |
| Total Depreciation and Amortization | 2.18% | 0.66% | -1.38% | -3.30% | -5.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 90.04% | 70.34% | 62.92% | 53.26% | 34.16% |
| Change in Net Operating Assets | 77.66% | -451.69% | -28.03% | 3.58% | -497.37% |
| Cash from Operations | -24.15% | -40.36% | -54.89% | -30.53% | -677.24% |
| Capital Expenditure | 23.45% | 33.36% | 8.11% | 34.23% | 15.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 23.45% | 33.36% | 8.11% | 34.23% | 15.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 84.02% | -72.04% | 117.07% | 104.89% | 80.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 233.46% | -100.17% | -- | -- | -- |
| Cash from Financing | 92.30% | -73.30% | 129.77% | 117.46% | 91.57% |
| Foreign Exchange rate Adjustments | 108.70% | -234.78% | 191.47% | 95.95% | -45.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 194.77% | -167.04% | 387.95% | 325.52% | -9.03% |